SCHEMBL903370

SCHEMBL903370

CCCCC[C@H](C)C(=O)C(C)C

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.61
ACE2 Q9BYF1 1/20 0.50
FDPS P14324 4/20 0.46
FFAR1 O14842 2/20 0.45
FFAR4 Q5NUL3 1/20 0.45
GPR84 Q9NQS5 4/20 0.45
NFKB1 P19838 1/20 0.44
MAPT P10636 1/20 0.43
TP53 P04637 1/20 0.43
LCK P06239 1/20 0.43
PPARD Q03181 1/20 0.43
ZDHHC20 Q5W0Z9 1/20 0.43
ZDHHC2 Q9UIJ5 1/20 0.43
OPRM1 P35372 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12180653 1.00 CA1 (0.61) CA1ACE2FDPSFFAR1FFAR4
SCHEMBL8062662 0.98 CA1 (0.59) CA1ACE2FDPSFFAR1FFAR4
SCHEMBL15544421 0.98 CA1 (0.59) CA1ACE2FDPSFFAR1FFAR4
SCHEMBL12044394 0.93 CA1 (0.52) CA1ACE2FDPSFFAR1FFAR4
SCHEMBL351185 0.90 CA1 (0.74) CA1ACE2FDPSFFAR1FFAR4
SCHEMBL1321582 0.88 CA1 (0.71) CA1ACE2FDPSFFAR1FFAR4
SCHEMBL3231557 0.88 CA1 (0.71) CA1ACE2FDPSFFAR1FFAR4
SCHEMBL3211014 0.88 CA1 (0.71) CA1ACE2FDPSFFAR1FFAR4
SCHEMBL1922411 0.88 CA1 (0.71) CA1ACE2FDPSFFAR1FFAR4
SCHEMBL2710871 0.88 CA1 (0.71) CA1ACE2FDPSFFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013025490-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES CERULEAN PHARMA INC. (US) 2013-02-21 WO disclosed
WO-2012044832-A1 METHODS OF TREATING A SUBJECT AND RELATED PARTICLES, POLYMERS AND COMPOSITIONS FETZER OLIVER S (US) 2012-04-05 WO disclosed
WO-2011146638-A1 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASES CERULEAN PHARMA INC. (US) 2011-11-24 WO disclosed
WO-2011090940-A1 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY CERULEAN PHARMA INC. (US) 2011-07-28 WO disclosed
WO-2009061596-A1 COMPOUNDS FOR INHIBITING KSP KINESIN ACTIVITY SCHERING CORPORATION (US) 2009-05-14 WO disclosed